Novavax Inc said on Friday its experimental COVID-19 vaccine showed immune response and protection against the highly contagious coronavirus variant originally identified in South Africa in a clinical trial. The vaccine, NVX-CoV2373, is being tested in multiple trials but has yet to be authorized for use in any country. Novavax also said studies in mice and baboons found that a different …
Read More »Novavax says COVID-19 vaccine shows immune response against Beta virus variant
June 12, 2021